Drug pricing, with receipts.
Independent analysis and open, fixture-backed standards for the data underneath drug coverage and pricing—who asserted what, when, on what evidence, and what receipt proves it. Published when there’s something worth paying attention to.
Or start with the essays →Standards
UDDL v0.1 — liveOpen technical profiles for contested healthcare data, starting with unit-level drug discount disposition. Schemas, synthetic fixtures, and receipts that make MFP / 340B disputes auditable.
Read UDDL v0.1 →Newsletter
The AdjudicatorThe primary release channel—coverage intel, disposition watch, and standards updates, right when they ship.
Subscribe →Advisory
WaitlistCoverage clarity audits, effectuation-plan design reviews, and reconciliation posture assessments—for teams navigating MFP, 340B, and access-data risk.
Join the waitlist →